chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
WOODWARD TE and RABY WT | Aureomycin in treatment of experimental and human tularemia. | 1949 | J Am Med Assoc | pmid:18124272 |
PERRY TL | Failure of aureomycin in the treatment of experimental tuberculosis. | 1949 | Proc. Soc. Exp. Biol. Med. | pmid:15391671 |
PELCAK EJ et al. | Comparative effectiveness of aureomycin, chloromycetin, penicillin, and streptomycin in vitro against various microorganisms isolated from hospital patients; preliminary report. | 1949 | Harlem Hosp Bull | pmid:15392126 |
Macht DI and Farkas R | Aureomycin and Blood Coagulation. | 1949 | Science | pmid:17838574 |
Broschard RW et al. | Aureomycin, a New Antibiotic. | 1949 | Science | pmid:17800953 |
WRIGHT LT and SCHREIBER H | The clinical value of aureomycin; a review of current literature and some unpublished data. | 1949 | J Natl Med Assoc | pmid:18139592 |
OLSHAKER B and ROSS S | Aureomycin in the treatment of pneumonia in infants and children. | 1949 | N. Engl. J. Med. | pmid:18139711 |
PETERSON NV and HADLEY RB | Aureomycin; its use in chronic and acute infections; preliminary report. | 1949 | Eye Ear Nose Throat Mon | pmid:18148234 |
RANDALL RV et al. | Intravenous administration of aureomycin including studies on the concentration in the serum. | 1949 | Proc Staff Meet Mayo Clin | pmid:15399063 |
HERRELL WE | Observations on the clinical use of aureomycin. | 1949 | Proc Staff Meet Mayo Clin | pmid:15399064 |